ProCE Banner Activity

Newest Viral Hepatitis Data From AASLD 2022

Podcast Episodes
Conference Coverage

Listen to expert insights from Stefan Zeuzem, MD, on updates and new viral hepatitis data from AASLD 2022, including data on HBV therapy during pregnancy, HBV therapeutic vaccines and progress toward HBV cure, HDV clinical impact and phase III clinical trial updates, and HCV implementation science and HCC risk reduction with use of DAAs.

Released: December 06, 2022

Share

Faculty

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD: consultant/advisor/speaker: AbbVie, BioMarin, Gilead Sciences, GlaxoSmithKline, Intercept, Janssen, MSD/Merck, Novo Nordisk, SoBi.